Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Phase 2 data for Roche’s lymphoma ADC doesn’t disappoint
Phase 2 data for Roche’s lymphoma ADC doesn’t disappoint
Phase 2 data for Roche’s lymphoma ADC doesn’t disappoint
Submitted by
admin
on December 12, 2017 - 10:10am
Source:
Fierce Biotech
News Tags:
Roche
ASH17
clinical trials
non-Hodgkin's lymphoma
antibody-drug conjugate
Headline:
Phase 2 data for Roche’s lymphoma ADC doesn’t disappoint
Do Not Allow Advertisers to Use My Personal information
